This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Philip Morris (PM) Q1 Earnings Top, View Reflects Coronavirus Woes
by Zacks Equity Research
Philip Morris' (PM) first-quarter 2020 results reflect earnings growth. However, management withdraws 2020 earnings view due to the coronavirus-led uncertainty.
Things You Must Know Ahead of Philip Morris' (PM) Q1 Earnings
by Zacks Equity Research
Philip Morris' (PM) first-quarter 2020 performance is likely to reflect favorable pricing and gains from RRPs. However, soft cigarette volumes might have been a concern.
Philip Morris (PM) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Philip Morris (PM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: Alphabet, Procter & Gamble, Philip Morris, Novo Nordisk and Tesla
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Alphabet, Procter & Gamble, Philip Morris, Novo Nordisk and Tesla
Factors Influencing Constellation Brands' (STZ) Q4 Earnings
by Zacks Equity Research
Constellation Brands' (STZ) fourth-quarter fiscal 2020 results are likely to reflect gains from the robust corona beer business, innovation pipeline and strong depletion growth.
Top Analyst Reports for Alphabet, Procter & Gamble & Philip Morris
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Alphabet (GOOGL), Procter & Gamble (PG) and Philip Morris International (PM).
Philip Morris Suspends Operations at MTB Due to Coronavirus
by Zacks Equity Research
Philip Morris (PM) will suspend all operations at Philip Morris Manufacturing & Technology Bologna S.p.A., Italy, for a week.
Why Is Philip Morris (PM) Up 1.3% Since Last Earnings Report?
by Zacks Equity Research
Philip Morris (PM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Philip Morris Focuses on RRPs Amid Low Cigarette Volumes
by Zacks Equity Research
Phillip Morris (PM) has been expanding in the RRP category. Also, the company's pricing strategy is providing cushion amid receding cigarette volumes.
Philip Morris (PM) Stock Moves -0.67%: What You Should Know
by Zacks Equity Research
Philip Morris (PM) closed at $85 in the latest trading session, marking a -0.67% move from the prior day.
Top Stock Analyst Reports for Merck, Philip Morris & American Tower
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Merck (MRK), Philip Morris International (PM) and American Tower (AMT).
Consumer Staples ETFs Shine on Philip Morris' Q4 Earnings Results
by Sweta Jaiswal, FRM
We highlight the impact of Philip Morris' Q4 earnings on ETFs with good exposure to the company.
Philip Morris (PM) Q4 Earnings Match Estimates, Revenues Beat
by Zacks Equity Research
Philip Morris' (PM) fourth-quarter 2019 results gain on favorable pricing. However, combustible category revenues remain soft.
Philip Morris (PM) Q4 Earnings Meet Estimates
by Zacks Equity Research
Philip Morris (PM) delivered earnings and revenue surprises of 0.00% and 0.43%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Philip Morris (PM) Ahead of Earnings?
by Zacks Equity Research
Philip Morris (PM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Here's How Philip Morris (PM) is Placed Ahead of Q4 Earnings
by Zacks Equity Research
Philip Morris' (PM) fourth-quarter 2019 results are likely to reflect gains from pricing and RRPs amid soft cigarette volumes.
Philip Morris (PM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Philip Morris (PM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Philip Morris Expands Smoke-Free Offerings With KT&G Alliance
by Zacks Equity Research
Philip Morris (PM) unveils an alliance with KT&G. The deal will allow it to commercialize KT&G's smoke-free products outside South Korea.
Why Philip Morris (PM) Could Beat Earnings Estimates Again
by Zacks Equity Research
Philip Morris (PM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's What You Should Note Ahead of Altria (MO) Q4 Earnings
by Zacks Equity Research
Altria's (MO) fourth-quarter 2019 results are likely to reflect gains from pricing and RRPs amid soft cigarette volumes.
Altria Focuses on Pricing & RRPs Amid Low Cigarette Volumes
by Zacks Equity Research
Altria's (MO) expansion in RRPs and focus on pricing bode well amid declining cigarette shipment volumes.
Philip Morris Battles Low Cigarette Volumes, Pricing Aids
by Zacks Equity Research
Philip Morris' (PM) performance is bearing adverse impacts of declining cigarette sales volume. However, expansion in RRPs and strong pricing are significant upsides.
Tobacco Industry Outlook Cushioned by RRP Strength & Pricing
by Vrishali Bagree
Regulatory headwinds and growing health consciousness are weighing on cigarette sales. Nevertheless, tobacco players are gaining from efficient pricing and strength in RRPs.
The Zacks Analyst Blog Highlights: Facebook, Alibaba, Mastercard, Abbott Laboratories and Philip Morris International
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Facebook, Alibaba, Mastercard, Abbott Laboratories and Philip Morris International
Top Stock Reports for Facebook, Alibaba & Mastercard
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Facebook (FB), Alibaba Group (BABA) and Mastercard (MA).